pelvic recurrence

临床试验

计划入组 383 人 · 首次发布于 2014 年 11 月 17 日

Unknown

NCT04127435

High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors

计划入组 50 人 · 首次发布于 2019 年 10 月 15 日

已完成

NCT05816980

Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients

计划入组 16 人 · 首次发布于 2023 年 4 月 18 日

药物

查看全部 17 →

Biotech

Approved

Bezlotoxumab(Zinplava)

相关疾病：Clostridium difficile infection recurrence

Small Molecule

Approved

Talc(Sclerosol, Steritalc)

相关疾病：Diaper Rash, Malignant Pleural Effusion，另有 1 项

H₂Mg₃O₁₂Si₄

Biotech

Approved

Fecal microbiota(Rebyota, VOWST)

相关疾病：Clostridioides Difficile Infection Recurrence

机构

查看全部 4 →

Greenwich LifeSciences

United States

Gamehost Inc

United States

Celtic Biotech Ltd.

Ireland

资讯

查看全部 1718 →

11个月前

Phase III BART Trial Shows Adjuvant Radiation Therapy Significantly Reduces Pelvic Recurrence in High-Risk Bladder Cancer

去年

Simple Hysterectomy Not Inferior to Radical Hysterectomy for Cervical Cancer Treatment

去年

临床试验

Beyond TME Origins

High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors

Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients

药物

Bezlotoxumab(Zinplava)

Talc(Sclerosol, Steritalc)

Fecal microbiota(Rebyota, VOWST)

机构

Greenwich LifeSciences

Gamehost Inc

Celtic Biotech Ltd.

资讯

Phase III BART Trial Shows Adjuvant Radiation Therapy Significantly Reduces Pelvic Recurrence in High-Risk Bladder Cancer

Simple Hysterectomy Not Inferior to Radical Hysterectomy for Cervical Cancer Treatment

RPLND Shows Promise in Early-Stage Seminoma, Reducing Need for Chemo